Dongkook Life Science Pursues Name Change to 'DK Luonix'
"Global Expansion and Business Expansion into the CMO Sector"
Dongkook Life Science said it held a board meeting on October 26 and resolved to pursue a name change to "DK Luonix" to expand its global market presence and strengthen the foundation for future growth.
Dongkook Life Science has focused on contrast media pharmaceuticals in the domestic market. It is pursuing a name change to reflect its commitment and vision to expand its medical imaging business into global markets, bring new MRI drugs to domestic and global markets, and grow its business into contract manufacturing (CMO).
A company official said, "We will become a company that strengthens its competitiveness across a broader range of markets, including not only the domestic medical imaging market but also global markets, while actively expanding new businesses that will lay the foundation for future growth."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Dongkook Life Science will hold an extraordinary general meeting of shareholders on December 11 to approve partial amendments to its articles of incorporation in connection with the name change.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
